Insider Transactions in Q1 2025 at Pliant Therapeutics, Inc. (PLRX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 23
2025
|
Mike Ouimette General Counsel & Corp. Sec'y |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+24.9%
|
-
|
|
Jan 23
2025
|
Lily Cheung Chief Human Resource Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,875
+33.91%
|
-
|
|
Jan 23
2025
|
Hans Hull Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,150
+13.76%
|
-
|
|
Jan 23
2025
|
Keith Lamont Cummings Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
56,650
+15.07%
|
-
|
|
Jan 23
2025
|
Eric Lefebvre Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,650
+15.97%
|
-
|
|
Jan 23
2025
|
Bernard Coulie President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
162,500
+21.51%
|
-
|
|
Jan 22
2025
|
Mike Ouimette General Counsel & Corp. Sec'y |
SELL
Open market or private sale
|
Direct |
10,230
-12.67%
|
$102,300
$10.99 P/Share
|
|
Jan 17
2025
|
Keith Lamont Cummings Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,148
-7.13%
|
$221,628
$11.2 P/Share
|
|
Jan 17
2025
|
Bernard Coulie President and CEO |
SELL
Open market or private sale
|
Direct |
52,419
-10.85%
|
$576,609
$11.2 P/Share
|
|
Jan 17
2025
|
Eric Lefebvre Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
18,478
-8.67%
|
$203,258
$11.2 P/Share
|
|
Jan 17
2025
|
Hans Hull Chief Business Officer |
SELL
Open market or private sale
|
Direct |
15,936
-7.01%
|
$175,296
$11.2 P/Share
|
|
Jan 17
2025
|
Mike Ouimette General Counsel & Corp. Sec'y |
SELL
Open market or private sale
|
Direct |
13,270
-14.11%
|
$145,970
$11.2 P/Share
|
|
Jan 17
2025
|
Lily Cheung Chief Human Resource Officer |
SELL
Open market or private sale
|
Direct |
3,740
-13.22%
|
$41,140
$11.2 P/Share
|